News releases from the National Institutes of Health (NIH)
Updated: 1 hour 43 min ago
Risk of heat-related health problems increases with age.
A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
NIH-funded study is the first look at antipsychotic prescriptions patterns in the U.S.
For preemies delivered by C-section, technique increases blood pressure, finds NIH-funded study.
Study will assess the safety and efficacy of gabapentin enacarbil for treating moderate to severe AUD.
Plan outlines aggressive timeline to achieve key milestones.
New members will serve terms through October 2017.
NIH team and colleagues believe microdevice may improve upon existing placenta models.
Trial to examine long-term health effects of Ebola virus disease.
Panel calls for more research and more opportunities for new investigators to invigorate the field.
Development could yield important new insights into how cancer spreads.
Scientists were able to identify small groups of VA patients with very high, predicted suicide risk.
Vision positions NLM as unifying force in biomedicine.
Program aims to identify molecules that contribute to a variety of health benefits.
He has served as Acting Director of the NINDS since October, 2014.
According the American Journal of Public Health (AJPH), significant disparities in the burden of disease and illness experienced by different groups persist.
Such large scale gene targeting in an animal model could be particularly useful for human genomic research.
A series of deficiencies require closure to implement corrective actions.
Findings indicate 3 percent or more of the U.S. population may have a genetic condition.